3.24.1.1.u2 html 181 296 1 false 69 0 false 6 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.acastipharma.com/20240331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Loss and Comprehensive Loss Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-consolidated-statements-of-loss-and-comprehensive-loss Consolidated Statements of Loss and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Shareholder's Equity Sheet http://www.acastipharma.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity Consolidated Statements of Shareholder's Equity Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-consolidated-statements-of-cash-flows- Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995455 - Disclosure - Note 1 - Nature of Operations Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-note-1-nature-of-operations Note 1 - Nature of Operations Notes 9 false false R10.htm 995465 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 10 false false R11.htm 995475 - Disclosure - Note 3 - Fair Value Measurements Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote3FairValueMeasurements Note 3 - Fair Value Measurements Notes 11 false false R12.htm 995485 - Disclosure - Note 4 - Receivables Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote4Receivables Note 4 - Receivables Notes 12 false false R13.htm 995505 - Disclosure - Note 5 - Equipment Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote5Equipment Note 5 - Equipment Notes 13 false false R14.htm 995515 - Disclosure - Note 6 - Intangible assets and Goodwill Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwill1 Note 6 - Intangible assets and Goodwill Notes 14 false false R15.htm 995525 - Disclosure - Note 7 - Trade and Other Payables Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote7TradeAndOtherPayables1 Note 7 - Trade and Other Payables Notes 15 false false R16.htm 995535 - Disclosure - Note 8- Leases Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8Leases Note 8- Leases Notes 16 false false R17.htm 995545 - Disclosure - Note 9 -Shareholders' Equity Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote9ShareholdersEquity1 Note 9 -Shareholders' Equity Notes 17 false false R18.htm 995555 - Disclosure - Note 10 - Stock Based Compensation Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockBasedCompensation Note 10 - Stock Based Compensation Notes 18 false false R19.htm 995565 - Disclosure - Note 11 - Loss Per Share Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote11LossPerShare Note 11 - Loss Per Share Notes 19 false false R20.htm 995575 - Disclosure - Note 12 - Income Taxes Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxes1 Note 12 - Income Taxes Notes 20 false false R21.htm 995635 - Disclosure - Note 13 - Commitments and Contingencies Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote13CommitmentsAndContingencies1 Note 13 - Commitments and Contingencies Notes 21 false false R22.htm 995645 - Disclosure - Note 14 - Restructuring Costs Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote14RestructuringCosts Note 14 - Restructuring Costs Notes 22 false false R23.htm 995665 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.acastipharma.com/20240331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies 23 false false R24.htm 995685 - Disclosure - Note 3 - Fair Value Measurements (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote3FairValueMeasurementsTables Note 3 - Fair Value Measurements (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote3FairValueMeasurements 24 false false R25.htm 995695 - Disclosure - Note 4 - Receivables (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote4ReceivablesTables Note 4 - Receivables (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote4Receivables 25 false false R26.htm 995705 - Disclosure - Note 5 - Equipment (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote5EquipmentTables Note 5 - Equipment (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote5Equipment 26 false false R27.htm 995715 - Disclosure - Note 6 - Intangible assets and Goodwill (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwillTables Note 6 - Intangible assets and Goodwill (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwill1 27 false false R28.htm 995725 - Disclosure - Note 7 - Trade and Other Payables (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote7TradeAndOtherPayablesTables Note 7 - Trade and Other Payables (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote7TradeAndOtherPayables1 28 false false R29.htm 995745 - Disclosure - Note 8 - Leases (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8LeasesTables Note 8 - Leases (Tables) Tables 29 false false R30.htm 995755 - Disclosure - Note 9 - Shareholders' Equity (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote9ShareholdersEquityTables Note 9 - Shareholders' Equity (Tables) Tables 30 false false R31.htm 995765 - Disclosure - Note 10 - Stock Based Compensation (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockBasedCompensationTables Note 10 - Stock Based Compensation (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockBasedCompensation 31 false false R32.htm 995775 - Disclosure - Note 11 - Loss per share (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote11LossPerShareTables Note 11 - Loss per share (Tables) Tables 32 false false R33.htm 995785 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesTables Note 12 - Income Taxes (Tables) Tables http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxes1 33 false false R34.htm 995825 - Disclosure - Note 1 - Nature of Operation (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote1NatureOfOperationDetailsTextual Note 1 - Nature of Operation (Details Textual) Details http://www.acastipharma.com/20240331/taxonomy/role/statement-note-1-nature-of-operations 34 false false R35.htm 995835 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details 35 false false R36.htm 995865 - Disclosure - Note 3 - Fair Value Measurements (Additional Information) (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote3FairValueMeasurementsAdditionalInformationDetails Note 3 - Fair Value Measurements (Additional Information) (Details) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote3FairValueMeasurementsTables 36 false false R37.htm 995875 - Disclosure - Note 3 - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote3FairValueMeasurementsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails Note 3 - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 37 false false R38.htm 995885 - Disclosure - Note 4 - Receivables - Receivables (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote4ReceivablesReceivablesDetails Note 4 - Receivables - Receivables (Details) Details 38 false false R39.htm 995905 - Disclosure - Note 4 - Acquisition of Grace - Assets Acquired and Liabilities Assumed (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote4AcquisitionOfGraceAssetsAcquiredAndLiabilitiesAssumedDetails Note 4 - Acquisition of Grace - Assets Acquired and Liabilities Assumed (Details) Details 39 false false R40.htm 995935 - Disclosure - Note 4 - Acquisition of Grace (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote4AcquisitionOfGraceDetailsTextual Note 4 - Acquisition of Grace (Details Textual) Details 40 false false R41.htm 995945 - Disclosure - Note 5 - Equipment - Schedule of equipment (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote5EquipmentScheduleOfEquipmentDetails Note 5 - Equipment - Schedule of equipment (Details) Details 41 false false R42.htm 995955 - Disclosure - Note 5 - Equipment - Schedule of equipment (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote5EquipmentScheduleOfEquipmentDetailsTextual Note 5 - Equipment - Schedule of equipment (Details Textual) Details 42 false false R43.htm 995965 - Disclosure - Note 6 - Intangible assets and Goodwill (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwillDetailsTextual Note 6 - Intangible assets and Goodwill (Details Textual) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwillTables 43 false false R44.htm 995975 - Disclosure - Note 6 - Intangible assets and Goodwill- Schedule of Intangible Assets in Process Research and Development (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsInProcessResearchAndDevelopmentDetails Note 6 - Intangible assets and Goodwill- Schedule of Intangible Assets in Process Research and Development (Details) Details 44 false false R45.htm 995985 - Disclosure - Note 6 - Intangible assets and Goodwill - Schedule of Goodwill (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote6IntangibleAssetsAndGoodwillScheduleOfGoodwillDetails Note 6 - Intangible assets and Goodwill - Schedule of Goodwill (Details) Details 45 false false R46.htm 995995 - Disclosure - Note 7 - Trade and Other Payables - Trade and Other Payables (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote7TradeAndOtherPayablesTradeAndOtherPayablesDetails Note 7 - Trade and Other Payables - Trade and Other Payables (Details) Details 46 false false R47.htm 996005 - Disclosure - Note 8 - Leases - Supplemental balance sheet information (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8LeasesSupplementalBalanceSheetInformationDetails Note 8 - Leases - Supplemental balance sheet information (Details) Details 47 false false R48.htm 996015 - Disclosure - Note 8 - Leases - Supplemental lease expense (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8LeasesSupplementalLeaseExpenseDetails Note 8 - Leases - Supplemental lease expense (Details) Details 48 false false R49.htm 996025 - Disclosure - Note 8 - Leases - Schedule of Lease Costs Recognized for Operating Leases (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8LeasesScheduleOfLeaseCostsRecognizedForOperatingLeasesDetails Note 8 - Leases - Schedule of Lease Costs Recognized for Operating Leases (Details) Details 49 false false R50.htm 996035 - Disclosure - Note 8 - Leases (Additional Information) (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8LeasesAdditionalInformationDetails Note 8 - Leases (Additional Information) (Details) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote8LeasesTables 50 false false R51.htm 996045 - Disclosure - Note 9 - Shareholder's Equity - Schedule Of Derivative Liabilities At Fair Value (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote9ShareholdersEquityScheduleOfDerivativeLiabilitiesAtFairValueDetails Note 9 - Shareholder's Equity - Schedule Of Derivative Liabilities At Fair Value (Details) Details 51 false false R52.htm 996055 - Disclosure - Note 9 - Shareholders' Equity - Fair Value Measurement Inputs and Valuation Techniques (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote9ShareholdersEquityFairValueMeasurementInputsAndValuationTechniquesDetails Note 9 - Shareholders' Equity - Fair Value Measurement Inputs and Valuation Techniques (Details) Details 52 false false R53.htm 996065 - Disclosure - Note 9 - Shareholders' Equity (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote9ShareholdersEquityDetailsTextual Note 9 - Shareholders' Equity (Details Textual) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote9ShareholdersEquityTables 53 false false R54.htm 996075 - Disclosure - Note 10 - Stock Based Compensation (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockBasedCompensationDetailsTextual Note 10 - Stock Based Compensation (Details Textual) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockBasedCompensationTables 54 false false R55.htm 996085 - Disclosure - Note 10 - Stock-based Compensation - Activities Within the Stock Option Plan (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockbasedCompensationActivitiesWithinTheStockOptionPlanDetails Note 10 - Stock-based Compensation - Activities Within the Stock Option Plan (Details) Details 55 false false R56.htm 996095 - Disclosure - Note 10 - Stock Based Compensation - Compensation Expense (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockBasedCompensationCompensationExpenseDetails Note 10 - Stock Based Compensation - Compensation Expense (Details) Details 56 false false R57.htm 996105 - Disclosure - Note 10- Stock-based compensation - Schedule of weighted average grant date fair value of awards for options granted (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote10StockbasedCompensationScheduleOfWeightedAverageGrantDateFairValueOfAwardsForOptionsGrantedDetails Note 10- Stock-based compensation - Schedule of weighted average grant date fair value of awards for options granted (Details) Details 57 false false R58.htm 996145 - Disclosure - Note 11 - Loss per share - Schedule of diluted net loss per share attributable to common shareholders (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote11LossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonShareholdersDetails Note 11 - Loss per share - Schedule of diluted net loss per share attributable to common shareholders (Details) Details 58 false false R59.htm 996185 - Disclosure - Note 12 - Income taxes - Income Tax (Recovery) Expense (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesIncomeTaxRecoveryExpenseDetails Note 12 - Income taxes - Income Tax (Recovery) Expense (Details) Details 59 false false R60.htm 996195 - Disclosure - Note 12 - Income Taxes - Reconciliation of Effective Tax Rate (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesReconciliationOfEffectiveTaxRateDetails Note 12 - Income Taxes - Reconciliation of Effective Tax Rate (Details) Details 60 false false R61.htm 996205 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesNetDeferredTaxAssetsDetails Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Details 61 false false R62.htm 996215 - Disclosure - Note 12 - Income Taxes - Tax Attributes and Temporary Differences Available to Reduce Future Years' Taxable Income (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesTaxAttributesAndTemporaryDifferencesAvailableToReduceFutureYearsTaxableIncomeDetails Note 12 - Income Taxes - Tax Attributes and Temporary Differences Available to Reduce Future Years' Taxable Income (Details) Details 62 false false R63.htm 996245 - Disclosure - Note 12 - Income Taxes - Government Assistance - Government Assistance (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesGovernmentAssistanceGovernmentAssistanceDetails Note 12 - Income Taxes - Government Assistance - Government Assistance (Details) Details 63 false false R64.htm 996255 - Disclosure - Note 12 - Income Taxes - Government Assistance - Unrecognized Federal Tax Credits Expirations (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesGovernmentAssistanceUnrecognizedFederalTaxCreditsExpirationsDetails Note 12 - Income Taxes - Government Assistance - Unrecognized Federal Tax Credits Expirations (Details) Details 64 false false R65.htm 996265 - Disclosure - Note 12 - Income Taxes - Government Assistance - (Additional Information) (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote12IncomeTaxesGovernmentAssistanceAdditionalInformationDetails Note 12 - Income Taxes - Government Assistance - (Additional Information) (Details) Details 65 false false R66.htm 996275 - Disclosure - Note 13 - Commitments and Contingencies (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote13CommitmentsAndContingenciesDetailsTextual Note 13 - Commitments and Contingencies (Details Textual) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote13CommitmentsAndContingencies1 66 false false R67.htm 996285 - Disclosure - Note 14 - Restructuring Costs (Additional Information) (Details) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote14RestructuringCostsAdditionalInformationDetails Note 14 - Restructuring Costs (Additional Information) (Details) Details http://www.acastipharma.com/20240331/taxonomy/role/DisclosureNote14RestructuringCosts 67 false false R68.htm 996305 - Disclosure - Assets Held for Sale (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureAssetsHeldForSaleDetailsTextual Assets Held for Sale (Details Textual) Details 68 false false R69.htm 996315 - Disclosure - Subsequent events (Additional Information) (Details Textual) Sheet http://www.acastipharma.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetailsTextual Subsequent events (Additional Information) (Details Textual) Details 69 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:TransfersOfFinancialAssetsAccountedForAsSaleValuationTechiques - acst-20240331.htm 8 acst-20240331.htm acst-20240331.xsd img181340459_0.jpg img181340459_1.jpg img181340459_2.jpg img181340459_3.jpg img181340459_4.jpg img181340459_5.jpg img181340459_6.jpg img181340459_7.jpg img181340459_8.jpg http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 false false